EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

A UVR-sensor wearable device intervention to reduce sun exposure in melanoma survivors: Results from a randomized controlled trial

Rachel Isaksson Vogel iD, Xianghua Luo iD, Katherine Brown, Patricia Jewett, Allison C Dona, Rebekah H Nagler, Rehana L Ahmed, Brian C Martinson, DeAnn Lazovich

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0281480 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS ONE, 2023. Verfasst von Rachel Isaksson Vogel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Gynecology and Women's Health, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, Minnesota, United St…. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Sunburn, Cancer Survivors. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NCATS NIH HHS, Melanoma Research Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Melanoma survivors are at increased risk of developing a second primary melanoma; however, some report sub-optimal sun behaviors and sunburns. We tested the effectiveness of a wearable device with ultraviolet radiation (UVR)-sensing technology to improve sun behaviors and reduce sunburns in cutaneous melanoma survivors. Materials and methods We conducted a randomized controlled trial using Shade 2, a commercially available wrist device that measures UVR. The intervention group received the device and mobile application notifications about their exposure and prompts to use sunscreen. The control group received the device and a separate research mobile application without information about their exposure or notifications. Participants wore the device for 12 weeks and self-reported sun behaviors before, during, and after the intervention. The primary outcome was a composite score of sun protection behaviors at week 12.

Results

386 participants were randomized (186 control, 182 intervention). Most were female and 5+ years past their first melanoma diagnosis. The average age was 56 years. Most (93%) completed the study, though 40% experienced device issues. No meaningful differences were observed in self-reported sun protection behaviors at week 12 (controls 3.0±0.5 vs. intervention 2.9±0.5, p = 0.06), any sunburn during the intervention period (controls 14.4% vs. intervention 12.7%, p = 0.75), or average daily objective UVR exposure (controls median 87 vs. intervention 83 J/m 2 , p = 0.43).

Conclusion

Wearing a device that measured and alerted melanoma survivors to UVR exposure did not result in different sun behaviors, exposure, or sunburns relative to controls. The technology needs refinement before further attempts to assess the effectiveness of self-monitoring UVR exposure. Clinical trials registration NCT03927742 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSkin NeoplasmsSunburnCancer SurvivorsHumansFemaleMiddle AgedMaleUltraviolet RaysSunlightSunscreening Agents

Substanzen

Sunscreening Agents

Autor:innen und Institutionen

  • Department of Obstetrics, Gynecology and Women's Health, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, Minnesota, United States of America.
  • Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America.
  • Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, United States of America.
  • Department of Medicine, Division of Hematology and Oncology, University of Minnesota, Minneapolis, Minnesota, United States of America.
  • Medical School, University of Minnesota, Minneapolis, Minnesota, United States of America.
  • Hubbard School of Journalism & Mass Communication, University of Minnesota, Minneapolis, Minnesota, United States of America.

ORCID-Profile: Rachel Isaksson Vogel, Xianghua Luo

Förderung

  • NCI NIH HHS
  • NCATS NIH HHS
  • Melanoma Research Alliance
  • American Cancer Society
  • National Institutes of Health
  • National Institute of Health
  • Masonic Cancer Center, University of Minnesota

Zitieren

APA

Vogel, R. I., Luo, X., Brown, K., Jewett, P., Dona, A. C., Nagler, R. H., Ahmed, R. L., Martinson, B. C., & Lazovich, D. (2023). A UVR-sensor wearable device intervention to reduce sun exposure in melanoma survivors: Results from a randomized controlled trial. PLOS ONE. https://doi.org/10.1371/journal.pone.0281480

Vancouver

Vogel RI, Luo X, Brown K, Jewett P, Dona AC, Nagler RH, et al. A UVR-sensor wearable device intervention to reduce sun exposure in melanoma survivors: Results from a randomized controlled trial. PLOS ONE. 2023. doi:10.1371/journal.pone.0281480

BibTeX
@article{Vogel2023,
  author = {Vogel, Rachel Isaksson and Luo, Xianghua and Brown, Katherine and Jewett, Patricia and Dona, Allison C and Nagler, Rebekah H and Ahmed, Rehana L and Martinson, Brian C and Lazovich, DeAnn},
  title = {A UVR-sensor wearable device intervention to reduce sun exposure in melanoma survivors: Results from a randomized controlled trial},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0281480}
}
Kostenlos starten →